Confounding factors of Alzheimer's disease plasma biomarkers and their impact on clinical performance
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Confounding factors of Alzheimer's disease plasma biomarkers and their impact on clinical performance
Authors
Keywords
-
Journal
Alzheimers & Dementia
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-09-25
DOI
10.1002/alz.12787
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease
- (2021) Alexis Moscoso et al. JAMA Neurology
- Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau
- (2021) Niklas Mattsson‐Carlgren et al. EMBO Molecular Medicine
- Detecting amyloid positivity in early Alzheimer's disease using combinations of plasma Aβ42/Aβ40 and p‐tau
- (2021) Shorena Janelidze et al. Alzheimers & Dementia
- Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer’s disease
- (2021) Joana B Pereira et al. BRAIN
- Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's disease
- (2021) D. O. T. Alawode et al. JOURNAL OF INTERNAL MEDICINE
- Comparing the Clinical Utility and Diagnostic Performance of Cerebrospinal Fluid P-Tau181, P-Tau217 and P-Tau231 Assays
- (2021) Antoine Leuzy et al. NEUROLOGY
- Phenotyping Alzheimer's disease with blood tests
- (2021) Kaj Blennow SCIENCE
- Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease
- (2021) Shorena Janelidze et al. JAMA Neurology
- Associations of amyloid and neurodegeneration plasma biomarkers with comorbidities
- (2021) Jeremy A. Syrjanen et al. Alzheimers & Dementia
- β-amyloid burden predicts prospective decline in body mass index in clinically normal adults
- (2020) Jennifer S. Rabin et al. NEUROBIOLOGY OF AGING
- Confounding effect of blood volume and body mass index on blood neurofilament light chain levels
- (2020) Ali Manouchehrinia et al. Annals of Clinical and Translational Neurology
- Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders
- (2020) Sebastian Palmqvist et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association of enlarged perivascular spaces and measures of small vessel and Alzheimers disease
- (2020) Eske Christiane Gertje et al. NEUROLOGY
- Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer’s disease
- (2020) Andréa L Benedet et al. BRAIN
- Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease
- (2019) Niklas Mattsson et al. JAMA Neurology
- High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis
- (2019) Suzanne E. Schindler et al. NEUROLOGY
- Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease–Related β-Amyloid Status
- (2019) Sebastian Palmqvist et al. JAMA Neurology
- CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts
- (2018) Oskar Hansson et al. Alzheimers & Dementia
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- High performance plasma amyloid-β biomarkers for Alzheimer’s disease
- (2018) Akinori Nakamura et al. NATURE
- Blood-based NfL
- (2017) Oskar Hansson et al. NEUROLOGY
- Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study
- (2016) Magnus Gisslén et al. EBioMedicine
- Plasma β-amyloid in Alzheimer’s disease and vascular disease
- (2016) Shorena Janelidze et al. Scientific Reports
- Cognitive Disorders and Dementia in CKD: The Neglected Kidney-Brain Axis
- (2013) J.-M. Bugnicourt et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C
- (2012) Lesley A. Inker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease
- (2011) Michael Ewers et al. NEUROBIOLOGY OF AGING
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation